• Sep 15, 2026

  $272.88-0.08%

  Comparable listed companies in the same services research group rose 1.78% on average on the day, while CRL was essentially flat [1].

  • 1Peer group

• Sep 14, 2026

  $273.11-1.85%

  CRL fell 1.85% even as comparable listed companies in the same services research group rose 1.14% on average, a divergence from peers [1], with the session trading on 1.9x the trailing average volume and a 4.6% intraday range [2].

  • 1Peer group
  • 2Market data

• Sep 11, 2026

  $278.26+1.93%

  Comparable listed companies in Services-Commercial Physical & Biological Research moved +0.34% on average, with 2 of 3 rising [1]. CRL's 1.93% gain outpaced that peer group move [1].

  • 1Peer group

• Sep 10, 2026

  $273.00-1.92%

  Comparable commercial physical and biological research companies fell 0.86% on average, and the stock's 1.92% decline was larger than that group's move [1].

  • 1Peer group

• Sep 9, 2026

  $278.35-0.86%

• Sep 8, 2026

  $280.76-2.68%

  CRL fell 2.68%, a steeper decline than the average -1.71% move seen among comparable Commercial Physical & Biological Research companies, all three of which also fell [1].

  • 1Peer group

• Sep 4, 2026

  $288.50-1.65%

  Comparable research services companies fell 0.92% on average, with all three peers in the group declining [1]. CRL's 1.65% decline came alongside this broader move among its peers, though it fell by a larger margin than the group average [1].

  • 1Peer group

Closing prices for CRL. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.